These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2288267)

  • 1. Some acute effects of smoking on endothelial cells and platelets.
    Davis JW
    Adv Exp Med Biol; 1990; 273():107-18. PubMed ID: 2288267
    [No Abstract]   [Full Text] [Related]  

  • 2. A trial of dipyridamole and aspirin in the prevention of smoking-induced changes in platelets and endothelium in men with coronary artery disease.
    Davis JW; Hartman CR; Shelton L; Ruttinger HA
    Am J Cardiol; 1989 Jun; 63(20):1450-4. PubMed ID: 2524959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Passive smoking affects endothelium and platelets.
    Davis JW; Shelton L; Watanabe IS; Arnold J
    Arch Intern Med; 1989 Feb; 149(2):386-9. PubMed ID: 2916883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiplatelet therapy.
    Sloan RW
    Am Fam Physician; 1981 Oct; 24(4):129-34. PubMed ID: 7025599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette-smoking affects platelets and endothelium in chronic hemodialysis patients.
    Davis JW; Arnold J; Wiegmann T
    Nephron; 1993; 64(3):359-64. PubMed ID: 8341380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Status of antiplatelet drugs in coronary heart disease.
    Mehta J; Mehta P
    JAMA; 1979 Jun; 241(24):2649-51. PubMed ID: 439365
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of drugs of platelets and complications of vascular disease.
    Mustard JF; Packham MA; Kinlough-Rathbone RL
    Adv Exp Med Biol; 1977; 82():94-105. PubMed ID: 920448
    [No Abstract]   [Full Text] [Related]  

  • 8. Aspirin and other platelet-aggregation inhibiting drugs.
    Gallus AS
    Med J Aust; 1985 Jan; 142(1):41-7. PubMed ID: 3880861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences between mainstream and sidestream tobacco smoke extracts and nicotine in the activation and aggregation of platelets subjected to cardiovascular conditions in diabetes.
    Yin W; Rubenstein DA
    Diab Vasc Dis Res; 2013 Jan; 10(1):57-64. PubMed ID: 22610271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combined effects of sidestream smoke extracts and glycated serum albumin on endothelial cells and platelets.
    Rubenstein DA; Morton BE; Yin W
    Cardiovasc Diabetol; 2010 Jul; 9():28. PubMed ID: 20604957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet function after cigarette smoking in relation to nicotine and carbon monoxide.
    Renaud S; Blache D; Dumont E; Thevenon C; Wissendanger T
    Clin Pharmacol Ther; 1984 Sep; 36(3):389-95. PubMed ID: 6467799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acute effects of passive smoking on peripheral vascular function.
    Argacha JF; Adamopoulos D; Gujic M; Fontaine D; Amyai N; Berkenboom G; van de Borne P
    Hypertension; 2008 Jun; 51(6):1506-11. PubMed ID: 18391102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute influence of smoking on platelet behaviour, endothelium and plasma lipids and normalization by aspirin.
    Blache D; Bouthillier D; Davignon J
    Atherosclerosis; 1992 Apr; 93(3):179-88. PubMed ID: 1534226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different effects of aspirin, dipyridamole and UD-CG 115 on platelet activation in a model of vascular injury: studies with extracellular matrix covered with endothelial cells.
    Eldor A; Vlodavsky I; Fuks Z; Muller TH; Eisert WG
    Thromb Haemost; 1986 Dec; 56(3):333-9. PubMed ID: 3551181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dipyridamole alone or combined with low-dose acetylsalicylic acid inhibits platelet aggregation in human whole blood ex vivo.
    Müller TH; Su CA; Weisenberger H; Brickl R; Nehmiz G; Eisert WG
    Br J Clin Pharmacol; 1990 Aug; 30(2):179-86. PubMed ID: 2206782
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelets and prostaglandins in coronary artery disease. Rationale for use of platelet-suppressive drugs.
    Mehta J
    JAMA; 1983 May; 249(20):2818-23. PubMed ID: 6341645
    [No Abstract]   [Full Text] [Related]  

  • 17. Platelet function inhibitors: their clinical use.
    Fuster V; Didisheim P
    Adv Intern Med; 1978; 23():251-64. PubMed ID: 343540
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet function studies in coronary artery disease. X. Effect of dipyridamole.
    Mehta J; Mehta P; Pepine CJ; Conti CR
    Am J Cardiol; 1981 May; 47(5):1111-4. PubMed ID: 7013461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of platelet suppressant treatment with dipyridamole and aspirin on exercise performance and platelet survival time in coronary disease.
    Steele P; Rainwater J; Vogel R
    Chest; 1981 Nov; 80(5):557-61. PubMed ID: 7297145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activation, adhesion, inflammation, and aggregation potential are altered in the presence of electronic cigarette extracts of variable nicotine concentrations.
    Hom S; Chen L; Wang T; Ghebrehiwet B; Yin W; Rubenstein DA
    Platelets; 2016 Nov; 27(7):694-702. PubMed ID: 27096416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.